These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Diprosone (betamethasone dipropionate) Creame 0-05%. Review and report of a multicentre study. Chambers WB; Cash WS; Marinaccio A J Int Med Res; 1976; 4(3 Suppl):1-26. PubMed ID: 799993 [No Abstract] [Full Text] [Related]
26. Topical steroids--which one? Wachs GN Int J Dermatol; 1973; 12(1):8-9. PubMed ID: 4694183 [No Abstract] [Full Text] [Related]
27. Treatment of granuloma telangiectaticum with 0.2 per cent fluocinolone acetonide cream. Kandil E Acta Derm Venereol; 1970; 50(2):140-2. PubMed ID: 4193918 [No Abstract] [Full Text] [Related]
28. [ON THE ANTI-INFLAMMATORY EFFECT OF DIFFERENT STEROID OINTMENTS ON THE HUMAN SKIN DETERMINED ON PYREXAL ERYTHEMA]. HEITE HJ; KALKOFF KW; KOHLER H Arzneimittelforschung; 1964 Mar; 14():222-6. PubMed ID: 14235994 [No Abstract] [Full Text] [Related]
29. [THE TOPICAL USE OF CORTICOSTEROIDS IN DERMATOLOGY]. POLANO MK Ned Tijdschr Geneeskd; 1965 Jan; 109():180-5. PubMed ID: 14301860 [No Abstract] [Full Text] [Related]
31. Penetration kinetics of four drugs in the human skin. Influences of various pharmaceutical vehicles on penetration in vitro. Zesch A; Schaefer H Acta Derm Venereol; 1974; 54(2):91-7. PubMed ID: 4133027 [No Abstract] [Full Text] [Related]
32. The effect of clobetasone butyrate and other topical steroids on skin thickness of the domestic pig. Winter GD; Wilson L Br J Dermatol; 1976 May; 94(5):545-50. PubMed ID: 1268065 [TBL] [Abstract][Full Text] [Related]
33. Kinetic study of the percutaneous absorption of 1,2,4-3H-labelled flupamesone. Rimbau V; Lleonart F Arzneimittelforschung; 1975 Jul; 25(7):1040-2. PubMed ID: 1174410 [TBL] [Abstract][Full Text] [Related]
34. Vasoconstrictor and systemic activities of topical steroids. Child KJ; English AF; Gilbert HG; Hewitt A; Woollett EA Arch Dermatol; 1968 Apr; 97(4):407-10. PubMed ID: 4966856 [No Abstract] [Full Text] [Related]
35. Percutaneous corticosteroid absorption correlated to partition coefficient. Katz M; Shaikh ZI J Pharm Sci; 1965 Apr; 54(4):591-4. PubMed ID: 5842347 [No Abstract] [Full Text] [Related]
36. [In vitro-penetration of radiolabelled hydrocortisone in various vehicles in human skin (author's transl)]. Zesch A; Schaefer H Arch Dermatol Forsch; 1973 May; 246(4):335-54. PubMed ID: 4758842 [No Abstract] [Full Text] [Related]
37. Topical corticosteroids for skin disorders. Med Lett Drugs Ther; 1966 May; 8(10):37-8. PubMed ID: 4223426 [No Abstract] [Full Text] [Related]
38. [Absorption of af 2071 (hydrocortisone-bendazac ester) after topical application compared with oral administration]. Catanese B; Barillari G; Rossi V Boll Chim Farm; 1978 Jun; 117(6):368-74. PubMed ID: 743382 [No Abstract] [Full Text] [Related]
39. Desonide, a potent nonfluorinated topical steroid, vasoconstriction assay and clinical trial. Smith EB; Gregory JF; Bartruff JK South Med J; 1973 Mar; 66(3):325-9. PubMed ID: 4570656 [No Abstract] [Full Text] [Related]
40. [Endocrine and metabolic effects of local corticotherapy]. Rimbaud P; Meynadier J Ann Dermatol Syphiligr (Paris); 1968; 95(3):253-62. PubMed ID: 5697206 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]